Techniques in Regional Anesthesia & Pain Management
Volume 11, Issue 1 , Pages 3-8 , January 2007

Fentanyl iontophoretic transdermal system: a review

  • Harold S. Minkowitz, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Harold S. Minkowitz, MD, Department of Anesthesiology, Memorial Hermann Memorial City Hospital, 921 Gessner Road, Houston, TX 77024.

References 

  1. Apfelbaum JL, Chen C, Mehta SS, et al. Poatoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534–540
  2. Rawal N, Allvin R The EuroPain Acute Pain Working Party. Acute pain services in Europe: a 17-nation survey of 105 hospitals. Eur J Anesthesiol. 1998;15:354–363
  3. Ashburn MA, Caplan RA, et al. American Society of Anesthesiologists Task Force on Acute Pain Management Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2004;100:1573–1581
  4. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. J Am Med Assoc. 1995;274:1874–1880
  5. International Association for the Study of Pain, Task Force on Acute Pain. Management of Acute Pain: A Practical Guide. Seattle, WA: IASP Publications; 1992;
  6. Agency for Health Care Policy and Research (PHSAHCPR). Acute Pain Management: Operative or Medical Procedures and Trauma. Public Health Service. Clinical Practice Guideline No. 1. Rockville, MD: US Department of Health and Human Services; 1992;
  7. Joint Commission on Accreditation of Healthcare Organizations. Pain Assessment and Management: An Organizational Approach. 2000;Oakbrook Terrace, IL
  8. Filos KS, Lehman KA. Current concepts and practices in postoperative pain management: need for a change?. Eur Surg Res. 1999;31:97–107
  9. Schafheutle EI, Cantrill JA, Noyce PR. Why is pain management suboptimal on surgical wards?. J Adv Nurs. 2001;33:728–737
  10. Bourne MH. Analgesics for orthopedic postoperative pain. Am J Orthop. 2004;33:128–135
  11. Sinatra RS, Torres J, Bustos AM. Pain management after major orthopaedic surgery: current strategies and new concepts. J Am Acad Orthop Surg. 2002;10:117–129
  12. Ballantyne JC, Carr DB, Chalmers TC, et al. Postoperative patient-controlled analgesia: meta-analyses of initial randomized control trials. J Clin Anesth. 1993;5:182–193
  13. Etches RC. Patient-controlled analgesia. Surg Clin North Am. 1999;79:297–312
  14. Koo PJS. Postoperative pain management with a patient-controlled transdermal delivery system for fentanyl. Am J Health Syst Pharm. 2005;62:1171–1176
  15. Campbell L. IV-related phlebitis, complications and length of hospital stay: 2. Br J Nurs. 1998;7(1372):1364–1370
  16. Vincente KJ, Kada-Bekhaled K, Hillel G, et al. Programming errors contribute to death from patient controlled analgesia: case report and estimate of probability. Can J Anaesth. 2003;50:328–332
  17. Ashburn MA, Love G, Pace NL. Respiratory related critical events with intravenous patient-controlled analgesia. Clin J Pain. 1994;1:52–56
  18. Callan CM. An analysis of complaints and complications with patient controlled analgesia. In:  Ferante FM,  Osteimer GW,  Covino BG editor. Patient Controlled Analgesia. Oxford: Blackwell Scientific Publications; 1990;p. 139–150
  19. Macario A: Systemic literature review of economics of IV patient controlled analgesia. American Society of Health-System Pharmacists 39th Midyear Clinical Meeting, December 5-9, 2004, Orlando, FL, Abstract SP 052
  20. IONSYS™ Full Prescribing Information. Raritan, NJ, Ortho-McNeil, Inc.
  21. Viscusi ER, Witkowski TA. Iontophoresis: the process behind noninvasive drug delivery. Reg Anesth Pain Med. 2005;30:292–294
  22. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14:101–114
  23. Curdy C, Kalia Y, Guy RH. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo. J Pharm Pharmacol. 2001;53:769–777
  24. Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61:2289–2307
  25. Peng PW, Sandler AN. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology. 1999;90:576–599
  26. Ashburn MA, Streisand J, Zhang J, et al. The iontophoresis of fentanyl citrate in humans. Anesthesiology. 1995;82:1146–1153
  27. Sathyan G, Jaskowiak J, Evashenk M, et al. Characterization of the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet. 2005;44(suppl 1):7–15
  28. Gupta SK, Southam M, Sathyan G, et al. Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system. J Pharm Sci. 1998;87:976–981
  29. Gupta SK, Bernstein KJ, Noorduin H, et al. Fentanyl delivery from an electrotransport system Delivery is a function of total current, not duration of current. J Clin Pharmacol. 1998;38:951–958
  30. Gupta SK, Sathyan G, Phipps B, et al. Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system. J Pharm Sci. 1999;88:835–841
  31. Chelly JE, Grass J, Houseman TW, et al. The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia A multicenter, placebo-controlled trial. Anesth Analg. 2004;98:427–433
  32. Viscusi ER, Reynolds L, Chung F, et al. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. J Am Med Assoc. 2004;291:1333–1341
  33. Gupta SK, Hwang S, Southam M, et al. Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet. 2005;44(suppl 1):25–32
  34. Sathyan G, Zomorodi K, Gidwani S, et al. The effect of dosing frequency on the pharmacokinetics of a fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet. 2005;44(suppl 1):17–24
  35. Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology. 1989;70:928–934
  36. Camu F, Van Aken H, Bovill JG. Postoperative analgesic effects of three demand dose sizes of fentanyl administered via patient controlled analgesia. Anesth Analg. 1998;87:890–895
  37. Koo PJS. Postoperative pain management with a patient controlled transdermal delivery system for fentanyl. Am J Health Syst Pharm. 2005;61:1171–1176
  38. Howell PR, Gambling DR, Pavy T, et al. Patient-controlled analgesia following cesarean section under general anaesthesia: a comparison of fentanyl with morphine. Can J Anaesth. 1995;42:415
  39. Lehmann KA, Heinrich C, van Heiss R. Balanced anesthesia and patient-controlled postoperative analgesia with fentanyl: minimum effective concentrations, accumulation and acute tolerance. Acta Anaesthiol Belg. 1988;39:11
  40. Viscusi ER, Reynolds L, Tait S, et al. An iontophoretic fentanyl patient controlled analgesic delivery system for postoperative pain: A double blind placebo controlled trial. Anesth Analg. 2006;102:188–194
  41. Brown CR, Moodie JE, Bisley EJ. Safety and efficacy of Transfenta in the treatment of postoperative pain: a double blind single center, placebo controlled trial. 1998;17th Annual Scientific Meeting of the American Pain Society, Nov 5-8, San Diego, CA 1998, 192#886
  42. Baird MB, Schug SA. Safety aspects of postoperative pain relief. Pain Digest. 1996;6:219
  43. Parker RK, Holtmann B, White PF. Patient-controlled analgesia (Does a concurrent opioid infusion improve pain management after surgery?). J Am Med Assoc. 1991;266:1947–1952
  44. Dal D, Kanbak M, Caglar M, et al. A background infusion of morphine does not enhance postoperative analgesia after cardiac surgery. Can J Anaesth. 2003;50:476–479
  45. Parker RK, Holtmann B, White PF. Effects of a nighttime opioid infusion with PCA therapy on patient comfort and analgesic requirements after abdominal hysterectomy. Anesthesiology. 1992;76:362
  46. Grass JA. Patient-controlled analgesia. Anesth Analg. 2005;101:s44–s61
  47. Sanansilp V, Lertakyamanee J, Udompunturak S. Cost-effectiveness Aalysis of patient-controlled analgesia, intramuscular q.i.d. injection and p.r.n. injection for postoperative pain relief. J Med Assoc Thai. 1995;78:600–604
  48. D’Haese J, Vanlersberghe C, Umbrain V, et al. Pharmacoeconomic evaluation of a disposable patient-controlled analgesia device and intramuscular analgesia in surgical patients. Eur J Anaesthesiol. 1998;15:297–303
  49. Macario A. Systematic literature review of the economics of intravenous patient-controlled analgesia. Pharmacy and Therapeutics. 2005;30:392–399
  50. Cullen DJ, Bates DW, Leape LL Adverse Drug Event Prevention Study Group. Prevention of adverse drug events: a decade of progress in patient safety. J Clin Anesth. 2000;12:600–614
  51. Choiniere M, Rittenhouse BE, Perreault S, et al. Efficacy and costs of patient-controlled analgesia versus regularly administered intramuscular opioid therapy. Anesthesiology. 1998;89:1377–1388
  52. Minkowitz HS, Damaraju CV, Hewitt DJ. Fentanyl HCl patient activated transdermal system (PATS): a pooled analysis of safety. Anesthesiology. 2006;105:A1645

PII: S1084-208X(07)00002-X

doi: 10.1053/j.trap.2007.02.001

Techniques in Regional Anesthesia & Pain Management
Volume 11, Issue 1 , Pages 3-8 , January 2007

Article Tools

* Image Usage & Resolution